← Back to graph
Biomarker

AST postprandial 2h

Selected indexed studies

  • Factors influencing the initial glycemic efficacy of dorzagliatin, a novel glucokinase activator, in type 2 diabetes. (Endocrine, 2025) [PMID:40560322]
  • A novel model for detecting advanced fibrosis in patients with nonalcoholic fatty liver disease. (Diabetes Metab Res Rev, 2022) [PMID:35938229]
  • Relations of hepatic steatosis with liver functions, inflammations, glucolipid metabolism in chronic hepatitis B patients. (Eur Rev Med Pharmacol Sci, 2018) [PMID:30229840]

_Worker-drafted node — pending editorial review._

Connections

No connections recorded yet.

Sources

Local graph